Aclarubicin-induced apoptosis and necrosis in cells derived from human solid tumours.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Mutation research

• Publication date

  2010-07-19

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.mrgentox.2010.04.013PMID 20399885
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Anthracyclines in the Treatment of Cancer

  2012cited by this paper
• Low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor for elderly patients with previously untreated acute myeloid leukemia.

  2010cited by this paper
• INO-1001, a novel inhibitor of poly(ADP-ribose) polymerase, enhances tumor response to doxorubicin

  2008cited by this paper
• [The efficacy of high-dose cytarabine for patients with t(8;21) AML and with normal karyotype AML].

  2008cited by this paper
• Aclarubicin-induced ROS generation and collapse of mitochondrial membrane potential in human cancer cell lines.

  2008cited by this paper
• Analysis of aclarubicin‐induced cell death in human fibroblasts

  2007cited by this paper
• Low concentrations of doxorubicin sensitizes human solid cancer cells to tumor necrosis factor‐related apoptosis‐inducing ligand (TRAIL)‐receptor (R) 2‐mediated apoptosis by inducing TRAIL‐R2 expression

  2007cited by this paper
• Transforming growth factor beta‐1 enhances cytotoxic effect of doxorubicin in human lung adenocarcinoma cells of A549 line

  2007cited by this paper
• Solamargine upregulation of Fas, downregulation of HER2, and enhancement of cytotoxicity using epirubicin in NSCLC cells.

  2007cited by this paper
• Evidence of a novel antiapoptotic factor: Role of inhibitor of differentiation or DNA binding (Id‐1) in anticancer drug‐induced apoptosis

  2007cited by this paper
• Nicotine decreases the cytotoxicity of doxorubicin towards MCF-7 and KB-3.1 human cancer cells in culture.

  2007cited by this paper
• Involvement of reactive oxygen species in aclarubicin-induced death of human trisomic and diabetic fibroblasts.

  2007cited by this paper
• Doxorubicin and selenium cooperatively induce fas signaling in the absence of Fas/Fas ligand interaction.

  2007cited by this paper
• Aclarubicin plus behenoyl cytarabine and prednisolone for previously treated acute myeloid leukemia patients

  2006cited by this paper
• Addition of 5-fluorouracil to doxorubicin-paclitaxel sequence increases caspase-dependent apoptosis in breast cancer cell lines

  2005cited by this paper
• Increase of doxorubicin sensitivity by doxorubicin-loading into nanoparticles for hepatocellular carcinoma cells in vitro and in vivo.

  2005cited by this paper
• Apoptosis: mechanisms and relevance in cancer

  2005cited by this paper
• Successful treatment of a patient with synchronous advanced non-small cell lung cancer and acute myeloid leukemia by a combination of gefitinib, low-dose cytarabine and aclarubicin.

  2005cited by this paper
• Reconstitution of caspase-3 sensitizes MCF-7 breast cancer cells to radiation therapy.

  2005cited by this paper
• Mechanisms of induction of apoptosis by anthraquinone anticancer drugs aclarubicin and mitoxantrone in comparison with doxorubicin: Relation to drug cytotoxicity and caspase-3 activation

  2005cited by this paper
• A novel CYR61-triggered ‘CYR61-αvβ3 integrin loop’ regulates breast cancer cell survival and chemosensitivity through activation of ERK1/ERK2 MAPK signaling pathway

  2005cited by this paper
• Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity

  2004cited by this paper
• A P-glycoprotein- and MRP1-independent doxorubicin-resistant variant of the MCF-7 breast cancer cell line with defects in caspase-6, -7, -8, -9 and -10 activation pathways.

  2004cited by this paper
• Induction of apoptosis and necrosis in A549 cells by the cis-Pt(II) complex of 3-aminoflavone in comparison with cis-DDP.

  2004cited by this paper
• Doxorubicin Induces Apoptosis in Normal and Tumor Cells via Distinctly Different Mechanisms

  2004cited by this paper
• Induction of apoptosis and necrosis in lymphocytes by the cis-Pt(II) complex of 3-aminoflavone in comparison with cis-DDP.

  2004cited by this paper
• Dual action of cyclin-dependent kinase inhibitors: induction of cell cycle arrest and apoptosis. A comparison of the effects exerted by roscovitine and cisplatin.

  2003cited by this paper
• Evaluation of An Aerosolized Selective COX-2 Inhibitor as a Potentiator of Doxorubicin in a Non-Small-Cell Lung Cancer Cell Line

  2003cited by this paper
• Automated quantification of apoptosis after neoadjuvant chemotherapy for breast cancer: early assessment predicts clinical response.

  2003cited by this paper
• Neoadjuvant chemotherapy with cisplatin, aclacinomycin A, and mitomycin C for cervical adenocarcinoma – a preliminary study

  2003cited by this paper
• Apoptosis: target of cancer therapy.

  2002cited by this paper
• Caspase‐3 is not essential for DNA fragmentation in MCF‐7 cells during apoptosis induced by the pyrrolo‐1,5‐benzoxazepine, PBOX‐6

  2002cited by this paper
• Comparison of anthracycline-induced death of human leukemia cells: Programmed cell death versus necrosis

  2002cited by this paper
• Lack of Correlation between Caspase Activation and Caspase Activity Assays in Paclitaxel-treated MCF-7 Breast Cancer Cells*

  2002cited by this paper
• Bcl-2 has differing effects on the sensitivity of breast cancer cells depending on the antineoplastic drug used.

  2002cited by this paper
• Apoptosis A Link between Cancer Genetics and Chemotherapy

  2002cited by this paper
• Hepatocyte Growth Factor/Scatter Factor Blocks the Mitochondrial Pathway of Apoptosis Signaling in Breast Cancer Cells*

  2001cited by this paper
• Dynamics of peroxisome assembly and function.

  2001cited by this paper
• Apoptosis and cancer chemotherapy.

  2001cited by this paper
• A comparison of the methods applied to detect apoptosis in genotoxically-damaged lymphocytes cultured in the presence of four antimutagens.

  2001cited by this paper
• Overexpression of BCL2 blocks TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in human lung cancer cells.

  2001cited by this paper
• Aclarubicin induces differentiation of leukemic progenitors in myelodysplastic syndrome cooperating with granulocyte colony-stimulating factor.

  2000cited by this paper
• Phase II protocol for the evaluation of new treatments in patients with advanced gastric carcinoma: results of ECOG 5282

  1999cited by this paper
• Expression of matrix metalloproteinases (MMP‐2 and ‐9) and tissue inhibitors of metalloproteinases (TIMP‐1 and ‐2) in acute myelogenous leukaemia blasts: comparison with normal bone marrow cells

  1999cited by this paper
• Structurally different anthracyclines provoke different effects on cell cycle and tumor B cell differentiation.

  1998cited by this paper
• Caspase-3 Is Required for DNA Fragmentation and Morphological Changes Associated with Apoptosis*

  1998cited by this paper
• Anthracyclines as tumor cell differentiating agents: effects on the regulation of erythroid gene expression.

  1997cited by this paper
• Anthracyclines in the treatment of cancer. An overview.

  1997cited by this paper
• Signal Transduction Pathways in Apoptosis

  1996cited by this paper
• Relationship between the tumour tissue pharmacokinetics and the antiproliferative effects of anthracyclines and their metabolites.

  1996cited by this paper
• Signal transduction pathways in apoptosis.

  1994cited by this paper
• Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of radiosensitivity.

  1987cited by this paper

• Aclarubicin: contemporary insights into its mechanism of action, toxicity, pharmacokinetics, and clinical standing

  2024cites this paper
• Disturbance of cellular homeostasis as a molecular risk evaluation of human endothelial cells exposed to nanoparticles

  2021cites this paper
• Transferrin-Bound Doxorubicin Enhances Apoptosis and DNA Damage through the Generation of Pro-Inflammatory Responses in Human Leukemia Cells

  2020cites this paper
• Aclarubicin in subtoxic doses reduces doxorubicin cytotoxicity in human non-small cell lung adenocarcinoma (A549) and human hepatocellular carcinoma (HepG2) cells by decreasing DNA damage.

  2019cites this paper
• Oxidative DNA Damage and Apoptosis Induced by Aclarubicin, an Anthracycline: Role of Hydrogen Peroxide and Copper

  2019cites this paper
• Aclarubicin, an anthracycline anti-cancer drug, fluorescently contrasts mitochondria and reduces the oxygen consumption rate in living human cells.

  2017cites this paper
• Prophylactic Effects of Dairy Kluyveromyces marxianus YAS through Overexpression of BAX, CASP 3, CASP 8 and CASP 9 on Human Colon Cancer Cell Lines

  2017cites this paper
• Early Activation of Apoptosis and Caspase-independent Cell Death Plays an Important Role in Mediating the Cytotoxic and Genotoxic Effects of WP 631 in Ovarian Cancer Cells.

  2016cites this paper
• Product Data Sheet Chemical Properties Product

  2016cites this paper
• Assessment of pro-apoptotic activity of doxorubicin-transferrin conjugate in cells derived from human solid tumors.

  2016cites this paper
• WP 631 and Epo B synergize in SKOV-3 human ovarian cancer cells.

  2014cites this paper
• The Connection between the Toxicity of Anthracyclines and Their Ability to Modulate the P-Glycoprotein-Mediated Transport in A549, HepG2, and MCF-7 Cells

  2014cites this paper
• Combined treatment of human colorectal tumor cell lines with chemotherapeutic agents and ionizing irradiation can in vitro induce tumor cell death forms with immunogenic potential

  2012cites this paper
• The role of reactive oxygen species in WP 631-induced death of human ovarian cancer cells: a comparison with the effect of doxorubicin.

  2011cites this paper